REGENERON PHARMACEUTICALS, INC. group: subsidiaries and structure
Business Corporation · NEW YORK, United States · LEI 549300RCBFWIRX3HYQ56
2subsidiaries
2countries
1held directly
0lapsed LEIs
0links on accounts older than 24 months
6ISINs of subsidiaries
Summary
REGENERON PHARMACEUTICALS, INC. is the ultimate parent of 2 subsidiaries with LEIs in 2 countries, as reported to GLEIF. 1 is held directly; the others sit below intermediate companies. The largest numbers are in Ireland (1) and in India (1). No subsidiary has a lapsed LEI, and no link rests on accounts older than 24 months. GLEIF's ISIN mapping lists 5 ISINs for the parent and 6 ISINs for its subsidiaries.
Written from GLEIF data using fixed, reviewed sentence templates.
Subsidiaries by country
Data-quality notes (AssetCensus analysis)
No group-level data-quality notes in this data release.
Group structure
Indentation shows the direct parent reported to GLEIF.
Subsidiaries
| Company | Country | City | LEI | Accounts year | Notes |
|---|---|---|---|---|---|
| REGENERON IRELAND DESIGNATED ACTIVITY COMPANY | Ireland | DUBLIN | 635400NABUOXXFAMHX81 | 2024 | |
| REGENERON INDIA PRIVATE LIMITED | India | BANGALORE | 335800DYBVNUYLGVHJ55 | 2025 |